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Abstract
Objective To compare the effects of pelvic floor muscle training and
watchful waiting on pelvic floor symptoms in a primary care population
of women aged 55 years and over with symptomatic mild pelvic organ
prolapse.
Design Randomised controlled trial.
Setting Dutch primary care.
Participants Women aged 55 years or over with symptomatic mild
prolapse (leading edge above the hymen) were identified by screening.
Exclusion criteria were current prolapse treatment or treatment in the
previous year, malignancy of pelvic organs, current treatment for another
gynaecological disorder, severe/terminal illness, impaired mobility,
cognitive impairment, and insufficient command of the Dutch language.
Interventions Pelvic floor muscle training versus watchful waiting.
Main outcomemeasures The primary outcome was change in bladder,
bowel, and pelvic floor symptomsmeasured with the Pelvic Floor Distress
Inventory-20 (PFDI-20), three months after the start of treatment.
Secondary outcomes were changes in condition specific and general
quality of life, sexual function, degree of prolapse, pelvic floor muscle
function, and patients’ perceived change in symptoms.
ResultsOf the 287 women who were randomised to pelvic floor muscle
training (n=145) or watchful waiting (n=142), 250 (87%) completed
follow-up. Participants in the intervention group improved by (on average)
9.1 (95% confidence interval 2.8 to 15.4) points more on the PFDI-20
than did participants in the watchful waiting group (P=0.005). Of women
in the pelvic floor muscle training group, 57% (82/145) reported an
improvement in overall symptoms from the start of the study compared
with 13% (18/142) in the watchful waiting group (P<0.001). Other
secondary outcomes showed no significant difference between the
groups.
Conclusions Although pelvic floor muscle training led to a significantly
greater improvement in PFDI-20 score, the difference between the groups
was below the presumed level of clinical relevance (15 points).
Nevertheless, 57% of the participants in the intervention group reported
an improvement of overall symptoms. More studies are needed to identify
factors related to success of pelvic floor muscle training and to investigate
long term effects.
Trial registration Dutch Trial Register (www.trialregister.nl) identifier:
NTR2047.
Introduction
Pelvic organ prolapse is a common condition characterised by
descent of the anterior or posterior vaginal wall, the uterus, or
the vaginal vault (after hysterectomy).1 In a Dutch community
survey, 75% of women aged 45-85 years had some degree of
prolapse.2 The prevalence of typical symptoms of prolapse
(seeing or feeling a vaginal bulge) is reported to be about
3-12%.2 3 Typical prolapse symptoms are thought to emerge
when the leading edge of the prolapse is at or below the
hymen.4 5 Women with milder forms of prolapse more often
experience other common prolapse related symptoms such as
pelvic pressure/heaviness or pelvic pain and urinary or bowel
symptoms. Treatment options include conservativemanagement
(pelvic floor muscle training or pessary treatment) and surgical
correction. However, surgery is associated with several
problems. Comorbidity and frailty canmake surgery undesirable,
and risks of complications and recurrence are considerable.
Finally, costs for prolapse related surgery are high and are
expected to substantially increase owing to the ageing population
and the higher prevalence of prolapse in older women.6
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Aswomenwith mild prolapse often experience mild symptoms,
surgery is generally not an option. However, evidence suggests
that women with symptomatic mild prolapse might benefit from
pelvic floor muscle training.7 8 There are two main hypotheses
on how pelvic floor muscle training may be effective in the
treatment of prolapse: descent of the pelvic floor is prevented
by teaching women to consciously contract their pelvic floor
muscles before and during any increase in abdominal pressure;
and structural support of the pelvic floor is improved by the
performance of pelvic floor muscle exercises, and, as a result,
the pelvic organs are held in place better.9 Beneficial effects of
pelvic floor muscle training in symptomatic stage 1 and/or 2
prolapse were shown in three small studies, of which two were
pilot studies7 8 and the other was of moderate methodological
quality.10 Other studies investigating the effect of pelvic floor
muscle training on prolapse also included women without
symptoms, women with more severe stage prolapse (at or below
the hymen), or both.11-14
Pelvic floor muscle training could typically be applied in
primary care. However, high quality studies on the effectiveness
of pelvic floor muscle training in women with symptomatic
(mild) prolapse in this setting are lacking. The aim of this study
was to compare the effects of pelvic floor muscle training and
watchful waiting on pelvic floor symptoms in a primary care
population of women aged 55 years or over with symptomatic
mild prolapse.
Methods
This was a randomised controlled trial comparing pelvic floor
muscle training and watchful waiting in women aged 55 years
or over with symptomatic mild pelvic organ prolapse. All
participants gave written informed consent. The study design
has been published in detail elsewhere.15
Participants
Participants were recruited from 15 Dutch general practices
between 14 October 2009 and 19 October 2012. Participating
general practitioners selected all women aged at least 55 years
who did not meet the study’s exclusion criteria. These included
current prolapse treatment or treatment in the previous year,
pelvic organ malignancy, current treatment for another
gynaecological disorder, severe/terminal illness, impaired
mobility, cognitive impairment, and insufficient command of
the Dutch language. The remaining women received a postal
five item screening questionnaire (web appendix 1) asking about
vaginal bulging, pelvic heaviness, urinary incontinence, and
vaginal splinting to assist micturition or defecation. Women
who responded positively to one or more screening questions
were invited to fill in another questionnaire and visit for a
baseline assessment.
A standardised interview about demographics and medical and
obstetric history was performed. Additionally, all women
underwent a physical examination and urinalysis for urinary
tract infection.When urinalysis showed a urinary tract infection,
participants were treated with antibiotics and afterwards filled
in a new questionnaire (which replaced the original baseline
questionnaire). The baseline physical examination comprised
measurement of post-void residual volume with an abdominal
ultrasound (BladderScan), evaluation of pelvic floor muscle
function,16 and Pelvic Organ Prolapse Quantification (POP-Q)
measurement.17 Physical examinations were performed by
research physicians who were trained in POP-Q measurement
and pelvic floor muscle function assessment by an experienced
urogynaecologist. Women with mild prolapse, defined as the
leading edge of the prolapse staying above the hymen (POP-Q
stage 1 and mild stage 2), were eligible for randomisation.
Interventions
Pelvic floor muscle training
Pelvic physiotherapists registered with the Dutch Pelvic
Physiotherapists’ Organisation treated all participants
randomised to pelvic floor muscle training. These
physiotherapists complete a three year specialisation course in
the diagnosis and treatment of pelvic floor disorders. Pelvic
floor muscle training was provided individually in face-to-face
contacts combined with home exercises. The pelvic
physiotherapists recorded the treatment modalities and the
number of treatment sessions for each participant. For all
participants, the intervention started with an explanation of the
function of the pelvis and the pelvic floor and about pelvic floor
dysfunctions; illustrations and three dimensional models of the
pelvis were used. Pelvic floor muscle function was assessed by
digital palpation. During this examination, the physiotherapists
also checked whether participants were able to correctly contract
(“squeeze and lift”) and relax their pelvic floor muscles. If
necessary, they used breathing exercises to increase awareness
of the pelvic floor. Participants who were not able to contract
or relax their pelvic floor muscles were first instructed how to
do this by being given feedback during digital palpation or, if
necessary, by application of myofeedback or electrical
stimulation. Participants who were able to control their pelvic
floor consciously but whose pelvic floor muscles were too weak
started training their pelvic floor by doing exercises. All
participants started with the same basic exercise scheme, to
which specific exercises could be added (web appendix 2).
The exercise programme was individualised and was modified
at each appointment on the basis of examination findings. In
cases of an overactive pelvic floor, the focus of the exercises
was on relaxation rather than on contraction and, if necessary,
general relaxation exercises were used. All participants were
taught to contract their pelvic floor muscles before and during
any increases in abdominal pressure (“the knack”), and attention
was paid to lifestyle (diet, body weight) and toilet habits (web
appendix 2). Initially, participants visited the pelvic
physiotherapist on a weekly basis, but when they were able to
correctly contract and relax their pelvic floor muscles the
intervals between appointments were extended (two to three
weeks). Participants were encouraged to continue practising at
home three to five times a week, twice or three times each day.
Watchful waiting
Participants randomised to watchful waiting received no
treatment and no recommendations.
Follow-up
Participants were scheduled for a follow-up appointment with
the research physician three months after the start of treatment
(or, in case of watchful waiting, three months after
randomisation). During the study period, participants were
allowed to visit their general practitioner or other caregiver for
any symptoms of prolapse; such visits were recorded at
follow-up.
Outcomes
The primary outcome of this trial was change in bladder, bowel,
and pelvic floor symptoms three months after the start of
treatment. Secondary outcomes were changes in condition
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specific and general quality of life, sexual functioning, degree
of prolapse, pelvic floor muscle function, and patients’ perceived
change in symptoms from the start of the study.
Measurements
We measured change in bladder, bowel, and pelvic floor
symptoms with the Pelvic Floor Distress Inventory-20
(PFDI-20). This patient completed questionnaire comprises
three subscales with scores ranging from 0 to 100: the Pelvic
Organ Prolapse Distress Inventory-6 assessing prolapse
symptoms, the ColoRectal-Anal Distress Inventory-8 assessing
colorectal/anal symptoms, and the Urinary Distress Inventory-6
assessing urinary symptoms. A higher PFDI-20 score (sum of
three subscale scores, range 0-300) indicates a higher symptom
burden.18 Wemeasured the effect of bladder, bowel, and pelvic
floor symptoms on daily life with the Pelvic Floor Impact
Questionnaire-7 (range 0-300, with higher scores indicating
greater effect).18 We used the Medical Outcomes Study Short
Form Health Survey-12 version 1 to measure general quality
of life.19 20 We measured sexual functioning with the Pelvic
Organ Prolapse/Incontinence Sexual Function Questionnaire-12
(range 0-48, with higher scores indicating better sexual
functioning).21 We assessed patients’ perceived change in
symptoms from the start of the study by using three questions
(are symptoms the same/better/worse?) with visual analogue
scale scores for improvement/deterioration (on a scale from
0-10).
We used the Pelvic Organ Prolapse Quantification system to
assess the degree of prolapse at baseline and follow-up. In the
POP-Q system, the degree of prolapse of the anterior vaginal
wall, the posterior vaginal wall, and the uterus or vaginal vault
(when there is a history of hysterectomy) is measured in
centimetres, using the hymnal remnants as a reference point.
Additionally, the genital hiatus, the perineal body, and the total
vaginal length (with the prolapse reduced) are measured. On
the basis of these findings, a POP-Q stage (0-4) is calculated
for each compartment. The overall POP-Q stage is equal to the
POP-Q stage of the most severely prolapsed compartment.17
Pelvic floor muscle function was examined by vaginal palpation
of the pelvic floor muscles in the lithotomy position.We defined
pelvic floor muscle function as normal (voluntary contraction
normal/strong, voluntary relaxation complete, involuntary
contraction and involuntary relaxation present), underactive
(voluntary contraction absent/weak, voluntary relaxation
complete, involuntary contraction absent/present, and
involuntary relaxation present), overactive (voluntary contraction
absent/weak/normal/strong, voluntary relaxation absent/partially
present, involuntary contraction and involuntary relaxation
absent/present), or inactive (voluntary contraction absent,
voluntary relaxation complete, involuntary contraction and
involuntary relaxation absent).16
Sample size
To detect a difference of 15 points (25% reduction in the
PFDI-20 score assuming a PDFI-20 baseline score of 60 points
and no change in the watchful waiting group15) with a standard
deviation of 36 points,22 a power of 80%, and a two sided α of
0.05, we needed 92 women in each treatment arm. Allowing
for a dropout rate of 15%, we needed a total of 216 women for
this trial.
Randomisation
We used blocked randomisation with variable block sizes to
randomise participants to one of the treatment arms in a one to
one ratio. An independent statistician who was not involved in
the enrolment of participants generated an allocation sequence.
The research physician used an external computer system with
an interactive voice response system (accessible by telephone)
to enrol participants in the study. This research physician was
blinded to allocation sequence and to both the ordering of the
blocks and their sizes.
Blinding
Participants, pelvic physiotherapists, and research physicians
were not blinded to group allocation. Research physicians and
pelvic physiotherapists were blinded to all answers on the
participant completed questionnaires, and research physicians
were blinded to the outcomes of the previous POP-Q
measurements and previous evaluations of pelvic floor muscle
function.
Statistical methods
We compared the difference in the change of questionnaire
scores (PFDI-20, Pelvic Floor Impact Questionnaire-7, Pelvic
Organ Prolapse/Incontinence Sexual FunctionQuestionnaire-12,
physical and mental component summary scores of general
quality of life) from baseline to follow-up between groups by
analysis of covariance using the follow-up score as the
dependent variable and baseline score, baseline POP-Q stage
(1 or 2), and previous prolapse treatment (more than one year
previously) (yes/no) as covariates.23 For the Pelvic Floor Impact
Questionnaire-7 scores, we used a square root transformation
to obtain a normal distribution of the residuals. We used logistic
regression analysis to assess whether patient perceived
improvement or worsening of symptoms, improvement or
worsening of POP-Q stage, and improvement or worsening of
pelvic floor muscle function (dependent variables) were
predicted by randomisation group (independent variable). We
applied a Bonferroni correction to correct the reported P values
for multiple testing.
We defined improvement/worsening of the POP-Q stage as
improvement or worsening of one or more POP-Q stages
(calculated for each compartment). We defined improvement
of pelvic floor muscle function as a change from abnormal
(underactive/overactive/inactive) at baseline to normal at
follow-up and worsening of pelvic floor muscle function as a
change from normal at baseline to abnormal at follow-up. We
imputed missing values in primary and secondary outcomes by
multiple imputation. The imputation model was based on a
missing value analysis and included the primary and secondary
outcomes of the study and the following variables: treatment
group, age, body mass index, parity, and previous prolapse
treatment. We compared results of the analyses on the
non-imputed dataset and analyses after multiple imputation to
assess the effect of multiple imputation on the outcomes. We
did all analyses according to the intention to treat principle. We
used a P<0.05 significance level for all statistical tests. We used
SPSS Statistics for Windows, version 20.0, for the analyses.
Results
In total, 145 women were allocated to pelvic floor muscle
training and 142 women to watchful waiting (figure⇓). Table
1⇓ shows the baseline characteristics of the study population.
Follow-up questionnaires were completed by 250 (87%)
participants, and the follow-up appointment was attended by
237 (83%). Median time from the start of treatment to
completing the questionnaires was 3.6 (interquartile range
3.0-4.3) months for women in the pelvic floor muscle training
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group and 3.2 (3.2-3.6) months in the watchful waiting group.
In total, 11 (8%) participants did not receive pelvic floor muscle
training and 19 (13%) discontinued the intervention prematurely
(figure⇓). For participants who completed the pelvic floor
muscle training intervention, the median number of treatments
was 7 (interquartile range 5-9). Myofeedback was used in 23
(16%) participants, and electric stimulation was used in 11 (8%).
At follow-up, 59 (41%) participants had not yet finished pelvic
floor muscle training.
In the intention to treat analysis, participants in the pelvic floor
muscle training group showed (on average) a 9.1 point greater
improvement on the Pelvic Floor Distress Inventory-20 scale
than participants in the watchful waiting group (P=0.005). For
the subscales, the difference between pelvic floor muscle
training and watchful waiting was significant on the Urinary
Distress Inventory-6 but not on the Pelvic Organ Prolapse
Distress Inventory-6 or ColoRectal-Anal Distress Inventory-8.
Sexual functioning (Pelvic Organ Prolapse/Incontinence Sexual
Function Questionnaire-12) and the physical and mental
component summary scores of general quality of life did not
change over time. Condition specific quality of life (Pelvic Floor
Impact Questionnaire-7) improved in both groups (difference
not significant) (table 2⇓). Of the participants in the pelvic floor
muscle training group, 57% reported an improvement in
symptoms from the start of the study. In the watchful waiting
group, improvement was reported by only 13%, and 81% of the
participants reported that their symptoms remained the same
(table 3⇓). The visual analogue scale scores of
improvement/deterioration showed no significant difference
between the groups (data not shown).
At follow-up, the proportion of participants with an
improvement of one or more POP-Q stages showed no
difference between the groups for any of the compartments
(table 4⇓). The proportion of women with deterioration of one
or more POP-Q stages was also the same in both groups for all
compartments. The proportion of women in whom pelvic floor
muscle function improved from baseline to follow-up was the
same in both groups in both the non-imputed and imputed
datasets (non-imputed: pelvic floor muscle training 27/106
(25%) versus watchful waiting 18/124 (15%) (corrected
P=0.117); imputed: pelvic floor muscle training 35/145 (24%)
versus watchful waiting 21/142 (15%) (corrected P=0.213)).
The proportion of women in whom pelvic floor muscle function
deteriorated between baseline and follow-up was the same in
both groups (data not shown).
No participants reported any adverse effects of pelvic floor
muscle training.
Discussion
Women with mild prolapse who received pelvic floor muscle
training showed greater improvement in symptoms than did
women randomised to a watchful waiting strategy. Although
the difference between the groups (9.1 points) was significant,
it was below the presumed level of clinical relevance (15 points).
Nevertheless, 57% of women in the pelvic floor muscle training
group reported symptomatic improvement compared with only
13% in the watchful waiting group. However, because this
patient reported outcome may be susceptible to recall bias and
social desirability bias, these results need to be interpreted with
caution. Nevertheless, women receiving pelvic floor muscle
training seemed to gain more insight into their symptoms and
underlying condition, leading to a higher subjective appreciation
of improvement than was reflected in the change in PFDI-20
scores. Another possibility is that a subgroup of women benefit
from pelvic floor muscle training, whereas others do not
experience any improvement. Further research might identify
factors related to the success of pelvic floor muscle training.
Typical symptoms of prolapse (such as seeing or feeling a
vaginal bulge) are thought to emerge when the leading edge of
the prolapse is at or below the hymen.4 5 Therefore, in women
with mild prolapse, other common prolapse related symptoms,
such as urinary and bowel symptoms, should be assessed. In
this study, in women with mild prolapse, pelvic floor muscle
training mainly affected the urinary symptoms. The largest
difference in mean change from baseline was achieved in the
PFDI-20 subscale measuring urinary symptoms (Pelvic Organ
Prolapse Distress Inventory-6). The other PFDI-20 subscales
(measuring prolapse and bowel symptoms) showed no
significant differences in change between the groups. The
relation between prolapse and urinary symptoms is not yet
completely understood. Although stress urinary incontinence
and prolapse are thought to be two coexisting problems that
share causative factors rather than having a cause and effect
relation,24 prolapse might cause bladder outlet obstruction,
leading to irritable bladder symptoms (urgency, urge
incontinence, frequency, nocturia).25 Stress urinary incontinence
is more common in women with mild prolapse,26 27 whereas
irritable bladder symptoms are thought to be more common in
women with advanced prolapse.25
Strengths and limitations of study
Themain strengths of this study are its sample size, its pragmatic
design with patient oriented outcome measures, and the fact
that it is the first study to compare pelvic floor muscle training
and watchful waiting in a primary care population of women
with a symptomatic mild prolapse. The study also has some
limitations. Because many women with prolapse symptoms do
not consult a physician,28 we chose to screen women for
symptoms possibly related to prolapse. Consequently, because
some women in our study population experienced only mild
symptoms at baseline, the mean PFDI-20 baseline score was
lower than those reported in similar studies. This might have
led to an underestimation of the effect of pelvic floor muscle
training because little room for improvement exists when
symptoms are mild at baseline.
Another limitation is that we did not use a standard pelvic floor
muscle training protocol. Instead, we chose a pragmatic
approach in which the participating pelvic physiotherapists
tailored the treatment to the needs of each participant. To
minimise the effect of any possible differences between pelvic
physiotherapists as regards their experience or skills, the pelvic
physiotherapists had to be registered with the Dutch Pelvic
Physiotherapists’ Organisation. As a consequence, all
participants were trained according to the same basic exercise
scheme. However, because we did not register the amount of
home exercises performed by the participants, we do not know
how strictly the participants adhered to their home exercise
programme.
Women in the control group received no active treatment or
recommendations. This choice was also pragmatic; because
women with mild prolapse often do not qualify for pessary
treatment or surgical correction, watchful waiting would be
usual practice for manywomenwith symptomatic mild prolapse.
We do not know to what extent women in the watchful waiting
group were influenced by the information they received about
prolapse at baseline; better understanding of their condition (for
example, knowing that they had a mild prolapse and what this
means) and its treatment options might have led to an
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;349:g7378 doi: 10.1136/bmj.g7378 (Published 22 December 2014) Page 4 of 11
RESEARCH
improvement in symptom burden. They may also have started
doing pelvic floor home exercises by themselves; however, as
this would also be the case in usual practice it is probably not
a great disadvantage.
Finally, the effect of pelvic floor muscle training compared with
watchful waiting was assessed after three months of treatment.
However, as not all participants had finished pelvic floor muscle
training at the moment of follow-up, the difference between the
groups might increase as the maximal effect of pelvic floor
muscle training had not yet been achieved. Also, rather than
relieving symptoms, pelvic floor muscle training might prevent
symptoms from getting worse. This implies that symptoms in
the pelvic floor muscle training group would remain stable
whereas those in the watchful waiting group would get worse
over time; this might also apply to the degree of prolapse.
However, the period of follow-up in this study was too short to
establish such a difference between the groups. We found no
difference in the change in pelvic floor muscle function between
the groups; this might also be related to the duration of
follow-up. Another possible explanation is that the method we
used for measuring pelvic floor muscle function may not be
sufficiently sensitive to small changes in pelvic floor muscle
function. However, as the clinical relevance of these small
changes is questionable, we think the method we used was
appropriate.
Comparison with other studies
To date, only three small studies have evaluated the effect of
pelvic floor muscle training on mild prolapse. Hagen et al
reported a pilot study in which 47 women with a symptomatic
stage 1-2 prolapse were randomised to pelvic floor muscle
training (n=23) or to a postal lifestyle advice sheet (n=24).7
Stüpp et al reported a pilot study in which 37 women with a
stage 2 prolapse were randomised to pelvic floor muscle training
(n=21) or control (n=16); women in the control group did not
consult a physiotherapist but received instructions on how to
perform pelvic floor muscle contractions and a lifestyle advice
leaflet.8 Ghroubi et al reported a trial in which 47 women with
stage 1-2 prolapse of the anterior vaginal wall were randomised
to pelvic floor muscle training (n=27) or no treatment (n=20).10
All three studies showed beneficial effects of pelvic floor muscle
training on symptoms; however, as two of themwere small pilot
studies and the other was of moderate methodological quality,
these results need to be confirmed in larger samples.
Furthermore, as all these studies were conducted in a hospital
setting, their conclusions might not be generalisable to the
primary care population.
More studies have investigated the effect of pelvic floor muscle
training on more severe stages of prolapse. The most rigorous
trial so far was by Hagen et al,14 who randomised 447 women
with symptomatic stage 1-3 prolapse to pelvic floor muscle
training or a lifestyle leaflet. Follow-up was at six and 12
months, and participants could be referred for further treatment
at six months. Pelvic floor muscle training led to a significantly
greater reduction in prolapse symptoms, with a difference in
mean change from baseline of 1.52 points on the Pelvic Organ
Prolapse SymptomScore between the groups (minimal clinically
important difference=1.529). No difference was seen in
improvement of bladder and bowel symptoms at 12 months.
The results of this trial are probably not generalisable to the
primary care population of women with mild prolapse (above
the hymen), as participants were recruited in a hospital setting
and 70% of them had an advanced prolapse (at or below the
hymen). Two other trials compared pelvic floor muscle training
with a control intervention. Braekken et al enrolled 109 women
with stage 1-3 prolapse who attended a gynaecologist with
prolapse symptoms or for a routine check-up and also women
who were just interested to know if they had a prolapse.Women
in the control group were advised to avoid straining and were
taught how to contract their pelvic floor muscles before and
during increases in abdominal pressure (the knack).11 Kashyap
et al randomised 140 women with stage 1-3 prolapse who
attended a gynaecology outpatient department with prolapse
symptoms. Women in the control group received a self
instruction manual with a home exercise programme but no
sessions with a pelvic physiotherapist.12 In both studies, pelvic
floor muscle training resulted in a greater improvement in
symptoms than did the control intervention. However, because
both studies included both asymptomatic women and women
with more severe stages of prolapse, these results are probably
also not generalisable to the primary care population of women
with only mild prolapse. Finally, Piya-Anant et al randomised
320 women with mild or advanced prolapse to pelvic floor
muscle training and 324 to control.13 Despite the sample size,
this study had considerable methodological shortcomings, and,
as it did not consider the effects of pelvic floor muscle training
on symptoms, the results cannot be compared with those of our
study.
Clinical interpretation of results
Although we found a significant difference between the groups,
this difference is probably not clinically relevant. Very limited
literature is available on the minimal clinically important
difference for the PFDI-20 questionnaire in women with mild
prolapse. In the design phase of this trial, we assumed a
difference of 15 points between groups to be clinically relevant.
The between treatment minimal clinically important difference
can be defined as the difference between the mean change in
PFDI-20 score in participants who report that their symptoms
are “the same” and those who report that symptoms are “a little
better” at follow-up compared with baseline. Gelhorn et al
studied the psychometric properties of the PFDI-20 in two
different populations of women undergoing prolapse surgery,
with baseline scores of 114.8 and 97.1, and found between
treatment minimal clinically important differences of 7.5 points
and 17.3 points, respectively.30Utomo et al studied the PFDI-20
in women with one or more pelvic floor symptoms who were
recruited in a tertiary urology and gynaecology clinic. They
found a between treatment minimal clinically important
difference of 19 points in a subgroup of patients undergoing
(conservative or surgical) treatment (baseline score 94.1 points:
personal communication E Utomo, 5 June 2014).31 However,
as the minimal clinically important difference may vary by
population and by context,32 these numbers might not be
generalisable to our primary care study population in which
PFDI-20 baseline scores were considerably lower.
We used a three point scale to assess patients’ perceived change
of symptoms from the start of the study (the same/better/worse).
The difference in the change in PFDI-20 score between women
who reported that symptoms were “the same” and those who
reported that they were “better” was 15.2 points. On the basis
of these findings, the difference between pelvic floor muscle
training and watchful waiting found in our study does not seem
to be clinically relevant. However, as the category “a little
better” was not available in our questionnaire, the actual between
treatment minimal clinically important difference of the PFDI-20
questionnaire in a primary care population might be lower.
Therefore, we do not know for sure whether the detected
difference of 9.1 points is clinically relevant in this population.
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Conclusions and policy implications
This is the first study to investigate the effects of pelvic floor
muscle training in a primary care population of women with
symptomatic mild prolapse, who were identified by screening.
We found a significant but presumably not clinically relevant
difference in the change in symptoms (PFDI-20) between the
groups. Nevertheless, as 57% of the participants in the pelvic
floor muscle training group reported that their symptoms had
improved, pelvic floor muscle training might be considered for
the treatment of women with bothersome symptomatic mild
prolapse who do not qualify for pessary treatment or surgical
correction. Further research might identify factors related to the
success of pelvic floor muscle training. Additionally, more
research on long term follow-up is needed to investigate whether
the effects of pelvic floor muscle training are sustained on the
long term and to establish whether pelvic floor muscle training
can prevent symptomatic mild prolapse from getting worse.
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What is already known on this topic
Pelvic floor muscle training seems to be effective in relieving symptoms of prolapse in women with an advanced stage pelvic organ
prolapse
High quality studies on the effectiveness of pelvic floor muscle training in women with symptomatic (mild) pelvic organ prolapse in a
primary care setting are lacking
What this study adds
In women with mild pelvic organ prolapse, the change in symptom score after three months differed significantly between pelvic floor
muscle training and watchful waiting/no treatment
However, the clinical relevance of this difference remains unclear
Women receiving pelvic floor muscle training were four times more likely to report a subjective improvement in overall symptoms than
were women receiving no treatment
Tables
Table 1| Baseline characteristics of all participants. Values are numbers (percentages) unless stated otherwise
Watchful waiting (n=142)Pelvic floor muscle training (n=145)Characteristics
64.0 (6.5)64.5 (6.8)Mean (SD) age, years
26.6 (4.8)27.0 (4.7)Mean (SD) body mass index, kg/m2
2.4 (1.1)2.4 (1.2)Mean (SD) parity
140 (99)142 (98)Postmenopausal
Educational level:






6 (4)13 (9)Pelvic floor surgery
18 (13)25 (17)Previous POP treatment*
Stage of POP†:
85 (60)70 (48)Stage 1





31 (22)30 (21)Anterior and posterior
19 (13)22 (15)Anterior and apical
4 (3)2 (1)Posterior and apical
6 (4)6 (4)Anterior and posterior and apical
59.0 (32.2)65.2 (39.9)Mean (SD) PFDI-20‡ score
13.6 (12.4)15.5 (13.4)Mean (SD) POPDI-6§ score
16.2 (14.4)17.2 (15.3)Mean (SD) CRADI-8¶ score
29.4 (15.8)32.4 (19.7)Mean (SD) UDI-6** score
POP=pelvic organ prolapse.
*Surgical or conservative POP treatment >1 year previously.
†Pelvic Organ Prolapse Quantification stage of most prolapsed compartment.
‡Pelvic Floor Distress Inventory-20 (range 0-300).
§Pelvic Organ Prolapse Distress Inventory-6 (range 0-100).
¶ColoRectal Anal Distress Inventory-8 (range 0-100).
**Urinary Distress Inventory-6 (range 0-100).
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Table 2| Change in mean (SD) questionnaire scores from baseline to follow-up
Difference (95% CI) in mean change from
baseline*; P valueWatchful waitingPelvic floor muscle training
Questionnaire Imputed dataUnimputed dataFollow-up scoreBaseline scoreFollow-up scoreBaseline score
−9.1 (−15.4 to −2.8);
0.005
−11.0 (−16.6 to −5.4);
<0.0001
51.3 (29.7); n=12759.0 (32.2); n=13846.9 (37.4); n=11765.2 (39.9); n=140PFDI-20†
−2.0 (−4.5 to 0.5);
0.110
−2.6 (−4.9 to −0.4 );
0.024
11.4 (11.3); n=12913.6 (12.4); n=14110.5 (12.3); n=11815.5 (13.4); n=145POPDI-6‡
−1.8 (−4.3 to 0.7);
0.165
−1.4 (−3.7 to 0.8);
0.209
13.6 (12.7); n=12816.2 (14.4); n=14013.7 (15.3); n=11817.2 (15.3); n=144CRADI-8§
−5.0 (−8.6 to −1.4);
0.007
−6.0 (−9.1 to −2.9);
<0.0001
26.3 (15.5); n=12929.4 (15.8); n=14022.8 (17.2); n=11832.4 (19.7); n=141UDI-6¶
0.03 (−0.5 to 1.1);
0.478
0.04 (−0.1 to 0.5);
0.441
11.7 (23.7); n=12012.1 (17.9); n=13118.0 (36.1); n=11022.1 (39.9); n=139PFIQ-7**
−0.1 (−2.3 to 2.1);
0.925
0.2 (−1.1 to 1.5);
0.715
37.1 (4.6); n=5836.4 (5.4); n=7035.5 (6.4); n= 4335.5 (5.3); n=64PISQ-12††
0.6 (−1.8 to 3.0);
0.606
1.5 (−0.4 to 3.5);
0.125
46.6 (10.4); n=12146.8 (9.7); n=13046.5 (10.3); n=11145.1 (10.5); n=122PCS-12‡‡
−0.9 (−2.7 to 0.8);
0.307
−0.6 (−2.3 to 1.0);
0.446
53.7 (8.3); n=12152.8 (8.5); n=13053.4 (7.1); n=11152.7 (8.5); n=122MCS-12§§
*Adjusted for baseline score, baseline Pelvic Organ Prolapse Quantification stage, and previous pelvic organ prolapse treatment (>1 year previously).
†Pelvic Floor Distress Inventory-20 (range 0-300).
‡Pelvic Organ Prolapse Distress Inventory-6 (range 0-100).
§ColoRectal Anal Distress Inventory-8 (range 0-100).
¶Urinary Distress Inventory-6 (range 0-100).
**Pelvic Floor Impact Questionnaire-7 (range 0-300).
††Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire-12 (range 0-48) (available only for women who were sexually active; missing scores were
imputed only for women who were sexually active at baseline).
‡‡Physical Component Health Summary (SF-12); 1998 norm based scores.
§§Mental Component Health Summary (SF-12).
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Table 3| Self reported change in symptoms from start of study. Values are numbers (percentages) unless stated otherwise
Imputed dataUnimputed data
Change P value*Watchful waiting† (n=142)PFMT† (n=145)P value*Watchful waiting (n=124)PFMT (n=115)
<0.00118 (13)82 (57)<0.00110 (8)70 (61)Better
<0.001115 (81)58 (40)<0.001106 (85)43 (37)Same
1.00017 (12)16 (11)0.2708 (6)2 (2)Worse
PFMT=pelvic floor muscle training.
*Logistic regression analysis, corrected P value (Bonferroni).
†Owing to multiple imputation, percentages do not add up to 100%.
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Table 4| Number (%) of participants with improvement of 1 or more Pelvic Organ Prolapse Quantification stages







*Logistic regression analysis, corrected P value (Bonferroni).
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Figure
Flow of participants through study. PFMT=pelvic floor muscle training. *No follow-up questionnaire available
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